Skip to main content
Premium Trial:

Request an Annual Quote

BGI Partners with PentaBase to Develop PCR-Based Dx Kits

NEW YORK (GenomeWeb News) – The Beijing Genome Institute and the Danish diagnostic developer PentaBase have agreed to co-develop disease detection kits using genetic biomarkers, PentaBase said today.
 
The agreement expands an ongoing collaboration with SD Genomics, which serves as BGI’s contact point in Denmark, that is focused on developing and launching real-time PCR-based diagnostics kits.
 
PentaBase sells primers and probes for real-time PCR applications, while BGI is a genetic sequencing center with more than 120 sequencing machines, 10 supercomputers, and 500 terabytes of storage, the companies said in a statement.
 
Terms of the alliance were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.